Grippferon Nazal Spray. scrapper. 10000me / ml 10ml 200doz 500me / dose vial 1 piece

Description

Composition
Active substance:
1 ml of solution contains: interferon alpha-2b, recombinant human least 10,000 ME.
Excipients:
Disodium edetate dihydrate 0.5 mg Sodium chloride 4.1 mg Sodium hydrogen phosphate dodecahydrate 11.94 mg Potassium dihydrogen phosphate 4.54 mg, povidone-eight thousand. 10 mg Macrogol 4000 100 mg Purified water to 1 ml.
Description:
Transparent colorless or light yellow solution.
Product form:
Nasal spray metered 500 IU / dose, 1 vial – 200 doses. To 10 ml in plastic vials with a metering device. 1 bottle together with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity of interferon preparations and components included in the preparation.
Severe allergic diseases.
Dosage
500 IU / dose
Indications
Prevention and treatment of influenza and acute respiratory viral infections (ARI) in children and adults.
Interaction with other drugs
The use of intranasal vasoconstrictors, together with Grippferonom® not recommended, as it contributes to further desiccation of the nasal mucosa.
Overdose
Data on overdose of the drug available.
pharmachologic effect
Pharmacological group:
Cytokine – antiviral, immunomodulatory agent.
Pharmacodynamics:
The drug has immunomodulatory, anti-inflammatory and antiviral action.
Pharmacokinetics:
Intranasal application concentration of the active substance in the blood achieved significantly lower slipped detection (detection limit of interferon alpha-2b – 1.2 IU / ml) and has no clinical significance.
Pregnancy and breast-feeding
Grippferon® approved for use throughout the period of pregnancy. No limitations to the use of lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
Not noted.
special instructions
The drug does not affect the ability to drive and use machines.
Storage conditions
At a temperature of 2 ° C to 8 ° C. Keep out of the reach of children.
Dosing and Administration
Grippferon® At the first sign of the disease is applied for 5 days:
aged 0 to 1 year 1 dose injected (500 ME) in each nostril 5 times a day (single dose of 1000 ME, the daily dose of 5000 ME);
aged 1 to 3 years old are injected with 2 doses in each nostril 3-4 times a day (single dose of 2000 ME, the daily dose of 6000-8000 ME);
aged 3 to 14 years are injected at 2 doses in each nostril 4-5 times a day (single dose of 2000 ME, the daily dose of 8000-10000 ME);
from 15 years and adults injected 3 doses in each nostril 5-6 times a day (single dose of 3000 ME, the daily dose of 15000-18000 ME).
With a view to the prevention of SARS and influenza:
when in contact with patients and / or drug injected undercooling in a single age dosage 2 times a day, once;
the seasonal increase in the incidence of drug is injected once in the morning age dosage intervals of 24-48 hours;
prevention courses are repeated, if necessary.
For administration of the drug should remove the protective cap, to introduce a spray device in the nasal passage and strongly press the atomizing mechanism (1 intake – 1 press). Before the first use to be several times to press the spray mechanism until a cloud of spray.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist